The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study.

BACKGROUND AND OBJECTIVES: Value-based healthcare (VBHC) is considered to be the solution that will improve quality and decrease costs in healthcare. Many hospitals are implementing programs on the basis of this strategy, but rigorous scientific reports are still lacking. In this pilot study, we present the first-year outcomes of a VBHC program for inflammatory bowel disease (IBD) management that focuses on highly coordinated care, task differentiation of providers, and continuous home monitoring. METHODS: IBD patients treated within the VBHC program were identified in an administrative claims database from a commercial insurer allowing comparisons to matched controls. Only patients for whom data were available the year before and after starting the program were included. Healthcare utilization including visits, hospitalizations, laboratory and imaging tests, and medications were compared between groups. RESULTS: In total, 60 IBD patients treated at the VBHC Center were identified and were matched to 177 controls. Significantly fewer upper endoscopies were performed (-10%, P=0.012), and numerically fewer surgeries (-25%, P=0.49), hospitalizations (-28%, 0=0.71), emergency department visits (-37%, P=0.44), and imaging studies (-25 to -86%) were observed. In addition, 65% fewer patients (P=0.16) used steroids long term. IBD-related costs were 16% ($771) lower than expected (P=0.24). CONCLUSION: These are the first results of a successfully implemented VBHC program for IBD. Encouraging trends toward fewer emergency department visits, hospitalizations, and long-term corticosteroid use were observed. These results will need to be confirmed in a larger sample with more follow-up.

Quality improvement for medicaid members of a commercial health plan: impact on racial/ethnic differences.

OBJECTIVE: To describe one commercial Medicaid Managed Care (MMC) health plan's quality improvement (QI) program that achieved high varicella immunization rates among members of an ethnically diverse population in California. DESIGN: Retrospective study using administrative data. PATIENTS: Blue Cross of California Medicaid enrolled children who turned two years old during each calendar year of the study. INTERVENTION: A specialized immunization strategy was implemented with data collected at three time points, pre-intervention (baseline--1998/1999), two-year followup (2001) and three-year followup (2002). MAIN OUTCOME MEASURE: Varicella vaccination coverage after the QI initiative. RESULTS: A statistically significant increase in varicella immunization rates for the study population was observed between baseline (49.5%) and three-year follow up (89.4%). Baseline differences in immunization rates by physician type and patient ethnicity were reduced. CONCLUSION: Trends in varicella vaccination coverage among members of this commercial MMC plan are in line with trends in overall vaccination coverage in California, indicating that commercial MMC health plans have the capacity to offer accessible and high quality care to ethnically diverse patients to mediate racial/ethnic differences. More work is needed to explore the impact of quality improvement programs of MMC plans in other areas.